How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/anemia-due-to-chemotherapy-for-nonmyeloid-cancer.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Anemia due to chemotherapy for nonmyeloid cancer — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Anemia due to chemotherapy for nonmyeloid cancer (disease) competitive landscape: 2 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

2 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Anemia due to chemotherapy for nonmyeloid cancer, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	Line of therapy	First approval
Neorecormon	EPOETIN BETA	Roche Registration Limited		Erythropoietin receptor		1997-01-01
Neorecormon	Neorecormon	Centre Hospitalier Universitaire, Amiens		Erythropoietin receptor

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

Centre Hospitalier Universitaire, Amiens · 1 drug in Anemia due to chemotherapy for nonmyeloid cancer
Roche Registration Limited · 1 drug in Anemia due to chemotherapy for nonmyeloid cancer

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Anemia due to chemotherapy for nonmyeloid cancer:

Cite this brief

Drug Landscape (2026). Anemia due to chemotherapy for nonmyeloid cancer — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/anemia-due-to-chemotherapy-for-nonmyeloid-cancer. Accessed 2026-06-10.

Anemia due to chemotherapy for nonmyeloid cancer full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing